Growing evidence suggests that close appositions between the endoplasmic reticulum (ER) and other membranes, including appositions with the plasma membrane (PM), mediate exchange of lipids between these bilayers. The mechanisms of such exchange, which allows lipid transfer independently of vesicular transport, remain poorly understood. The presence of a synaptotagmin-like mitochondrial-lipidbinding protein (SMP) domain, a proposed lipid-binding module, in several proteins localized at membrane contact sites has raised the possibility that such domains may be implicated in lipid transport 1,2 . SMP-containing proteins include components of the ERMES complex, an ER-mitochondrial tether 3 , and the extended synaptotagmins (known as tricalbins in yeast), which are ER-PM tethers 4-6 .
Growing evidence suggests that close appositions between the endoplasmic reticulum (ER) and other membranes, including appositions with the plasma membrane (PM), mediate exchange of lipids between these bilayers. The mechanisms of such exchange, which allows lipid transfer independently of vesicular transport, remain poorly understood. The presence of a synaptotagmin-like mitochondrial-lipidbinding protein (SMP) domain, a proposed lipid-binding module, in several proteins localized at membrane contact sites has raised the possibility that such domains may be implicated in lipid transport 1, 2 . SMP-containing proteins include components of the ERMES complex, an ER-mitochondrial tether 3 , and the extended synaptotagmins (known as tricalbins in yeast), which are ER-PM tethers [4] [5] [6] .
Here we present at 2.44 Å resolution the crystal structure of a fragment of human extended synaptotagmin 2 (E-SYT2), including an SMP domain and two adjacent C2 domains. The SMP domain has a b-barrel structure like protein modules in the tubular-lipid-binding (TULIP) superfamily. It dimerizes to form an approximately 90-Ålong cylinder traversed by a channel lined entirely with hydrophobic residues, with the two C2A-C2B fragments forming arched structures flexibly linked to the SMP domain. Importantly, structural analysis complemented by mass spectrometry revealed the presence of glycerophospholipids in the E-SYT2 SMP channel, indicating a direct role for E-SYTs in lipid transport. These findings provide strong evidence for a role of SMP-domain-containing proteins in the control of lipid transfer at membrane contact sites and have broad implications beyond the field of ER-to-PM appositions.
ER-PM contact sites, which are present in all eukaryotes, are thought to have multiple functions [7] [8] [9] , including an evolutionarily conserved role in the regulation of lipid composition and metabolism at the PM [8] [9] [10] [11] . E-SYTs are ER-resident proteins that act as tethers linking the ER and PM membranes into close apposition [4] [5] [6] . There are three E-SYTs (E-SYT1, 2 and 3) in mammalian cells, which homo-or heterodimerize 6 . Each E-SYT has an amino-terminal ER-membrane anchor, followed by a short linker region, an SMP domain, and three or more C2 domains 6 (Fig. 1a) . The ER-membrane anchor and C2 domains are required for tethering, whereas the role of the SMP domain has been unclear 6 . Bioinformatics analyses suggesting that SMP domains belong to the TULIP superfamily were therefore intriguing because several TULIP proteins are known to bind lipids and participate in lipid transfer 1, 2 .
To obtain insights regarding E-SYT function, we determined the crystal structure of a fragment of human E-SYT2 (residues 163-634) comprising the SMP, C2A and C2B domains (Extended Data Table 1 ). The carboxyterminal portion of E-SYT2, which consists of an extended linker region followed by a third C2 domain (C2C) that interacts with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) at the PM 6 , was not in the construct.
This E-SYT2 fragment dimerizes both in solution, as assessed by sizeexclusion chromatography, and in the crystal. Each SMP domain is a b-barrel ( Fig. 1b) , comprising a highly twisted b-sheet and two a-helices, H1and H3. A third helix, H2, partially caps one end of the barrel. The other end of the barrel associates with the corresponding end of the second SMP domain to form a 90-Å -long cylinder. The residues at the interface of the two SMP domains are among the most highly conserved (Extended Data Fig. 1 ), consistent with the physiological relevance of the dimer, and they probably mediate homo-and heterodimerization of E-SYTs 6 . An approximately 10-Å -diameter channel lined exclusively with hydrophobic residues runs through the cylinder (Fig. 1c ). It connects with solvent at both ends and via a narrow seam along the length of the cylinder.
There is no significant similarity between the primary sequences of the E-SYT2 SMP domain and proteins of known fold. Nevertheless, as predicted by bioinformatics studies 1,2 , our structure firmly establishes the SMP domain as a member of the TULIP superfamily. In previously characterized TULIP proteins such as bactericidal/permeability-increasing protein (BPI) and cholesteryl ester transfer protein (CETP) ( Fig. 1d ), SMP-like modules also form tubular structures harbouring an elongated hydrophobic channel 12, 13 . BPI and CETP do not dimerize, however, as each monomer comprises two SMP-like domains rather than one, with the two modules arranged in tandem and connected by a b-sheet not present in E-SYTs. Within the SMP channel, the electron density maps show clear densities for two lipid-like molecules per E-SYT2 monomer ( Fig. 2a, b ). One density is consistent with a diacylglycerol lipid, whereas the other is reminiscent of Triton X-100, a detergent used in protein purification. Triton X-100 was modelled into this density with its 4-(1,1,3,3 tetramethylbutyl)-phenyl group buried within the hydrophobic channel and its hydrophilic polyethylene chain extended through the seam into the solvent (Fig. 2) . A non-denaturing mass spectrometry (MS) analysis 14 of recombinant E-SYT2 purified in the absence of Triton X-100 shows that ligand-bound proteins are present and that two lipid molecules can bind per monomer (Extended Data Fig. 2 ), so probably a second lipid molecule binds in place of the detergent in a physiological context. Denaturing negative-ionization high-resolution MS and MS/MS analysis further identified ligands of the recombinant E-SYT2 as two major components of the bacterial membrane, phosphatidylglycerol and phosphatidylethanolamine (PE) (Extended Data Fig. 3 and Extended Data Table 2 ).
The electron density maps show that the lipid fatty acid moieties lie in the hydrophobic channel, whereas the polar head group protrudes through the seam and is solvated. There is no density for the head group, implying that it does not make extensive contacts with E-SYT2 and is disordered. This suggests that the SMP domain could bind a variety of glycerophospholipids. BPI and CETP bind diverse lipids in a similar manner, with hydrophobic portions buried in the hydrophobic channel and the hydrophilic groups exposed to solvent along the seam 12, 13 .
To identify lipids bound to E-SYT2 in mammalian cells, a 33Flagtagged E-SYT2 fragment comprising the SMP and C2A-C2B domains was expressed in Expi293 cells and purified by anti-Flag immunoprecipitation. Denaturing MS of this construct and quantitative lipidomic analysis revealed the presence of the glycerophospholipids phosphatidylcholine (PC; 67%), PE (21%), phosphatidylinositol (7%) and phosphatidylserine (3%) (Extended Data Figs 4, 5 and Extended Data Table 3 ). These relative amounts of the major phospholipids roughly reflect their relative abundance in animal cell membranes 15 , suggesting a lack of specificity with respect to particular glycerophospholipid ligands. We looked for but did not detect other lipid species such as lysophosphatidylcholine, sphingosine or sphingosine-1-phosphate, sphingomyelin, 
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any phosphoinositides, or notable amounts of ceramide. Nor were cholesterol esters, which are bound by CETP 13 , or cholesterol detected. When analysed by non-denaturing MS, E-SYT2 was found to occur both as monomer and dimer (Fig. 2c ). The charge state distribution centred around 116 represents monomers mainly in the apo form, corresponding to a molecular weight of 57,030 dalton (Da) after deconvolution (Extended Data Fig. 6a ). Only a low percentage of the monomers (,10%) were bound to one or two lipid molecules, with masses corresponding to the main lipid species identified previously. Most of the protein was dimeric with a charge state distribution centred around 124. After deconvolution of this spectrum (Extended Data Figs 6b, c and 7), the molecular weight of the dimer is ,117,500 Da, suggesting the presence of at least four bound lipid molecules (assuming an average mass of 750-800 Da per lipid). Almost no dimers were detected in the apo form. These findings indicate that dimerization is required for stable binding of the lipids.
Binding to glycerophospholipids was also demonstrated in vitro by testing the ability of purified lipids to displace preloaded fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (NBD-PE) from E-SYT2 ( Fig. 2d, e ). Incubation of preloaded E-SYT2 with PC displaced NBD-PE, as revealed by loss of fluorescence in the band corresponding to E-SYT2 in native polyacrylamide gel electrophoresis (PAGE; Fig. 2e ). In contrast, consistent with the MS results, cholesterol, sphingomyelin and ceramide did not displace PE, suggesting that they are not bound by E-SYT2 even when abundantly present. The greater rigidity of these lipids as compared to glycerophospholipids may prevent their entry into the E-SYT2 lipidbinding site.
C2A and C2B both fold into type II C2 domains and are rigidly linked into an arch spanning ,70 Å across ( Fig. 3 shows best view of arch), as recently described 16 . In the crystal structure, both C2A-C2B modules of the E-SYT2 dimer contact the same SMP domain, with different C2A-C2B residues interacting with different patches on the SMP (Fig. 1a,  left) . Residues at the interfaces are not conserved (Extended Data Fig. 1 ), suggesting that the C2-SMP interactions are crystal contacts and that C2A-C2B does not interact with the SMP dimer in solution (Fig. 1b,  right) . Rather, the E-SYT2 C2A-C2B fragment interacts with lipid bilayers in a Ca 21 -dependent manner 17 . Accordingly, calcium-coordinating residues were identified in loops at the end of the arch structure in C2A 16 .
The distance between the ER and PM membranes at contact sites is estimated at 100-300 Å (refs 8, 18, 19) . E-SYT2 spans this space with an N-terminal membrane anchor inserted into the ER and its C2C domain bound to the PM via an interaction with PI(4,5)P 2 , which is enriched there 6 (Fig. 3) . Although C2C, when expressed alone, is recruited to the PM 6,17 , we and others 17 did not observe any association of C2A-C2B with a particular organelle in living cells. Given the geometric restraints imposed by domain dimensions and linker lengths, an interaction between C2A-C2B and the cytosolic surface of the ER is plausible and consistent with its previously observed acidic-phospholipid-independent membrane interactions 17 . An interaction between C2A-C2B and the PM at very narrow ER-PM contacts (less than ,100 Å ), where it can reach the PM, is also plausible, however.
The structure of the E-SYT2 SMP domain and identification of lipids in its hydrophobic channel conclusively establishes this domain as a lipid-binding module. The structural similarity of E-SYT2 to proteins in the TULIP superfamily, several of which function in lipid transfer extra-cytosolically 2,12,13 , further suggests a role in lipid transport. Moreover, the presence of this module in proteins that localize to contacts between the ER and other membranes 4-6,20 strongly indicates a role in the transfer of lipids from their site of synthesis in the ER to these membranes, such as the PM in the case of E-SYT2. In answer to how such a transfer may take place, SMP dimers could in principle form a bridge between apposed membranes along which lipids are transferred ('tunnel model'; Fig. 3 ), with their hydrophobic moieties sliding along the hydrophobic channel and their hydrophilic head groups solvent exposed at the seam. CETP was proposed to function in exactly this manner to channel cholesterol esters between lipoprotein particles 21 . However, as it is only 90 Å long, the E-SYT2 SMP dimer may be too short to span the inter-membrane space. Another possibility, plausible for ER-PM distances under ,200 Å , is that the SMP dimer shuttles between membranes, extracting lipid from one and delivering it to the second ('shuttle model'; Fig. 3 ). In a third, not mutually exclusive model, E-SYT2 functions in concert with other lipid transfer proteins to effect transport. This model is appealing because it does not require E-SYTs preferentially 
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to bind specific lipids, which could instead be selected by the partner proteins. Phosphatidylinositol transfer proteins (PITPs) and proteins in the OSH family are interesting candidates because they can interact with specific lipids 22, 23 and are thought to function in lipid transfer at contact sites 8, 9 .
The identification of E-SYTs as lipid transfer proteins represents an important step forward in dissecting the biology of ER-PM contact sites. Nevertheless, our work is also more generally applicable to other contact sites, such as ER-mitochondrial contacts, where the ERMES tethering complex is predicted to contain three SMP modules 1, 2 . We suspect that these hetero-dimerize in a head-to-head fashion, as observed in the E-SYT2 SMP homodimer, to form one or more lipid carrier modules with hydrophobic lipid-binding channels.
METHODS SUMMARY
Native or selenomethionine-substituted recombinant human E-SYT2 (residues 163-634) were overexpressed in and purified from Escherichia coli. The protein was crystallized by the hanging-drop method, equilibrating against mother liquor comprising 100 mM malonic acid, imidazole and boric acid (MIB) buffer at pH 4.3-4.6 and 12.5-14% PEG 1500, and additionally 0.1 M NaI for the selenomethionine-substituted protein. We used the multi-wavelength anomalous dispersion method with the selenomethionine-substituted crystals for phasing (Extended Data Table 1 ). The structure was refined against data from native crystals (Extended Data Table 1 ). Structure determination, MS analysis and in vitro lipid-binding assays are described in more detail in Methods.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Cloning, protein expression and purification. Human E-SYT2 (residues 163-634) was cloned into a modified pCDF vector, which codes for an N-terminal glutathione S-transferase (GST) tag and a Precision protease cleavage site. The plasmid was transformed into Escherichia coli BL21(DE3) cells. Cells were grown to an OD 600 nm 0.7, then shifted to 20 uC, and protein expression was induced by adding 1 mM isopropyl-b-D-thiogalactoside (IPTG). Cells were harvested 20 h after induction. Selenomethionine-substituted E-SYT2 was produced similarly to as described previously 24 . Cells were collected by centrifugation, resuspended in lysis buffer (20 mM Tris pH 8.0, 500 mM NaCl, 5 mM dithiothreitol (DTT), 10 mM EDTA) supplemented with protease inhibitors (Complete EDTA-free; Roche) and lysed using a cell disruptor (Avestin). E-SYT2 was isolated by glutathione sepharose resin, washed once with lysis buffer supplemented with 1% Triton X-100 and twice in lysis buffer, except without EDTA. The GST tag was cleaved off using Precision protease and the hexahistidine-tagged protease removed by passing the protein solution over Ni-NTA resin. The protein was further purified by gel filtration (Superdex 200; GE Healthcare), eluted in buffer containing 20 mM Tris (pH 8.0), 300 mM NaCl and 5 mM DTT, and concentrated to approximately 8 mg ml 21 .
For purification from mammalian cells, human E-SYT2 (residues 163-634) was cloned into pCDNA 3.1 with an N-terminal 33Flag tag. Expi293 cells were transfected for 3 days before harvesting. Cells were lysed in buffer (20 mM Tris pH 8.0, 250 mM NaCl, 10 mM EDTA) supplemented with protease inhibitors (Complete EDTA-free; Roche) by the freeze-thaw method using liquid nitrogen five times. Proteins were purified by anti-Flag M2 resin (Sigma) and eluted in buffer (20 mM Tris pH 8.0, 250 mM NaCl) containing 100 mg ml 21 33Flag peptide. Further purification was by size-exclusion chromatography, as described earlier. Crystallization, data collection and structure determination. Crystals of native protein were grown at room temperature by the hanging-drop method. Equal volumes of protein solution and mother liquor (1.3 ml) were mixed and suspended over mother liquor (100 mM malonic acid, imidazole and boric acid (MIB) buffer (Qiagen) at pH 4.3, 12.5% PEG 1500). The crystals belong to spacegroup P2 1 2 1 2 1 , with a 5 74.3, b 5 88.4, c 5 167.2 Å . Selenomethionine-substituted crystals were grown under similar conditions, except that the mother liquor additionally contained sodium iodide (100 mM MIB (Qiagen) at pH 4.6, 14% PEG 1500, 0.1 M NaI). Crystals were transferred to mother liquor supplemented with 16% ethylene glycol, loop-mounted and flash frozen in liquid nitrogen. For the selenium-substituted crystals, data were collected at two wavelengths chosen to maximize the selenium and iodine anomalous signals. All data were collected at NE-CAT beamline 24-ID-C at the Advanced Photon Source and processed using XDS 25 . Phases were calculated in Phenix 26 by the multi-wavelength anomalous dispersion method using the data from the selenium-substituted crystals, and electron density maps were further improved by solvent flattening and non-crystallographic twofold averaging. We used COOT 27 for model building. As model building progressed, we iteratively combined phases calculated from partial models with experimental phases to improve the maps in still unbuilt regions. The model was refined to 2.44 Å against data from native crystals using Phenix 26 . Initial rounds of refinement were carried out using least squares, real space, individual B-factor and torsion angle annealing options and were alternated with manual rebuilding in COOT 27 . Detergent and lipid molecules as well as waters were modelled in the final stages of refinement, for which we used least squares, individual B-factor and TLS refinement options. Figures were prepared using PyMol software 28 . The model has good Ramachandran geometry (96%, 4% and 0.1% of the residues are in the allowed, generously allowed and disallowed regions, respectively). MS analyses. Purified protein samples were desalted with a Vivaspin 10,000 MWCO device (GE Healthcare) to exchange the initial buffer with 20 mM ammonium acetate, pH 6.8, and to eliminate eventually present contaminating small molecules. The sample was then directly infused at a flow of 1 ml min 21 and a concentration of 0.4 mg ml 21 into a quadruple time-of-flight (QTOF) 6550 Agilent mass spectrometer equipped with an Agilent 1200 series system. Non-denaturing analyses were performed in positive ion mode with nanoelectrospray voltage set to 1,400 V (Vcap), temperature 280 uC, drying gas flow 11 l min 21 and fragmentor 175 V. The samples were injected in 20 mM ammonium acetate, pH 6.8, and spectra acquired at a scan rate of 1 spectra s 21 . Data were collected over a mass range of 1,000-10,000 m/z and deconvoluted using Bioconfirm software (Agilent) and the Maximum Entropy deconvolution algorithm. Denaturing MS, to identify the possible ligands and to confirm the theoretical mass of apo E-SYT2, was performed in positiveand negative-ion mode using conditions that could break the protein-ligand complex (high vapour acidic solutions containing 5% acetic acid in 20 mM ammonium acetate). The same acidic conditions were also used to dissociate native dimers and to confirm that their presence was not an instrumental artefact. Data were acquired between 100 and 1,000 m/z (both positive and negative mode) to identify the ligands and between 1,000 and 10,000 m/z (positive mode) to monitor the protein conformational states. The structural identity of ligands was confirmed by collisioninduced dissociation (CID) in positive-and negative-ion mode after selection of precursor ions in MS/MS mode and fragmentation with a collision energy value of 25 eV.
To improve lipid identification, a lipid extract obtained by sonicating (10 min) the protein (4 mg) in 100 ml of methanol (or chloroform/methanol for extraction of neutral lipids) was collected after centrifugation of the sample and protein precipitation. The sample was then resuspended in solvent B (see later) and analysed by liquid chromatography (LC)-MS/MS with the same mass spectrometer equipped with a ChipLC system and a HILIC chip (Amide 80, Agilent) for the chromatographic separation of the isolated lipids. The Agilent 1200 series HPLC used a capillary pump for sample injection onto the Enrichment column and a Nano pump for separation. Solvents used for HILIC HPLC: 50% acetonitrile in water containing 25 mM ammonium formate pH 4.6 adjusted with formic acid (solvent A), 95% acetonitrile containing 25 mM ammonium formate pH 4.6 adjusted with formic acid (solvent B). LC gradient used: 100% B from 0 to 1.5 min, 100% to 85% B from 1.5 to 3 min, 85 to 80% B from 3 to 11.5 min, 100% B from 11.5 to 13.5 min, 100% B from 13.6 to 19 min. The Agilent 6550 QTOF mass spectrometer was operated in positive-ion mode and negative-ion mode; electrospray voltage was set to 1,580 V (Vcap), temperature 185 uC, drying gas 14 l min 21 , fragmentor voltage 175 V. The instrument was operated in auto MS/MS mode with an MS acquisition rate of 2 spectra s 21 and MS/MS acquisition rate of 4 spectra s 21 .
Quantification of the lipid species released from E-SYT2 expressed in mammalian cells was performed by LC-MS/MS (MRM mode) after spiking lipid standards in the sample before the extraction and using a 6460 QQQ (Agilent) mass spectrometer, equipped with a 1290 series chromatographic system. Lipid standards: 1, 2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS), 1,2-dimyristoyl-sn-glycero-3-phospho-(19-rac-glycerol) (DMPG), 1,2dihexadecanoyl-sn-glycero-3-phosphate (DPPA), 1-heptadecanoyl-2-hydroxy-snglycero-3-phosphate (LPA), N-heptadecanoyl-D-erythro-sphingosine (Cer) were purchased from Avanti polar lipids, dioctanoyl phosphatidylinositol (PI) was purchased from Echelon Biosciences. The experimental conditions and the transitions monitored to quantify the lipid species are reported together in Supplementary Methods. In vitro lipid binding assay, lipid loading. Gel-filtrated SMP-C2A-C2B (19 ml at ,2 mg ml 21 ) or C2A-C2B (at ,3 mg ml 21 ) in 20 mM Tris HCl pH 8, 150 mM NaCl and 5 mM DTT were mixed with 1 ml NBD-PE 16:0 at 1 mg ml 21 in methanol. The lipid control was 19 ml of the above buffer with 1 ml NBD-PE 16:0. They were incubated on ice for 1 h and visualized on a DTT-ontaining native PAGE gel. Fluorescence was visualized using Imagequant LAS4000 and protein via Coomassie staining. Only the SMP-containing construct binds NBD-PE. Lipid competition assay. NBD-PE-preloaded protein was obtained by incubating GST-SMP-C2A-C2B with NBD-PE as described earlier. To separate E-SYT2 from excess PE, GST-SMP-C2A-C2B was rebound to glutathione resin, washed, and cleaved off using Precision protease.
Lipids were dried under nitrogen and resuspended at 6.4 mM in methanol. Ceramide was heated to 42 uC to dissolve the lipid. Lipid (1 ml) was added to SMP-C2A-C2B preloaded with NBD-PE (19 ml at ,1 mg ml 21 ). Samples were incubated for 1 h at room temperature, then visualized on native gels as described earlier. Gel images were quantified using imageJ 29 . Fluorescent signal was normalized to the amount of protein in each lane, which was assessed by Coomassie staining.
